AntiAg Cancer Research Results

AntiAg, Antiplatelet aggregation: Click to Expand ⟱
Source:
Type:
Antiplatelet aggregation refers to the process by which platelets clump together to form a blood clot.
The plethora of evidence indicates that among multiple hemostasis components, platelets play major roles in cancer progression by providing surface and granular contents for several interactions as well as behaving like immune cells.On the other hand, there are suggestions that antiplatelet treatment may promote solid tumor development in a phenomenon described as “cancers follow bleeding.” The controversies around antiplatelet agents justify insight into the subject to establish what, if any, role platelet-directed therapy has in the continuum of anticancer management.
The interplay between antiplatelet aggregation and cancer is an area of active research, with potential implications for therapeutic strategies. Antiplatelet agents, such as aspirin, are being investigated for their role in cancer prevention and treatment, particularly in reducing metastasis and improving patient outcomes.


Scientific Papers found: Click to Expand⟱
3890- Cin,    The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases
- Review, CardioV, NA
*cardioP↑, *Inflam↓, *ROS↓, *lipid-P↓, *AntiAg↑, *angioG↑, *GutMicro↑, *ER Stress↓,
4337- CUR,    Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling
- in-vitro, Nor, NA
*AntiAg↑, *TXA2↓,
2466- CUR,    Regulatory Effects of Curcumin on Platelets: An Update and Future Directions
- Review, Nor, NA
*AntiAg↑, *antiOx↑, *Inflam↓, *12LOX↑, COX1↓, COX2/PTGS2↓, MMP9↓, NF-kB↓,
6705- DFC,    Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
- Review, Var, NA
*Inflam↓, *Pain↓, *COX1↓, *COX2/PTGS2↓, *toxicity↝, *BioAv↑, *AntiAg↑, *neuroP↑, ROS↑, p73↑, Myc↓, lactateProd↓, TumCCA↑, PI3K↓, Akt↓, NF-kB↓, SOD2↓, *neuroP↑,
6694- DFC,    Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
- Review, Var, NA
COX2/PTGS2↓, PGE2↓, angioG↓, ChemoSen↑, RadioS↑, Dose↝, toxicity↝, toxicity↝, BioAv↑, Half-Life↝, lactateProd↓, eff↑, *AntiAg↑,
8845- DIM,  I3C,    3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways
- Review, Var, NA
*BioAv↝, *BioAv↓, *BioAv↓, *AntiAg↑, *ROS↓, *AntiThr↑, *Stroke↓, *CYP1A1↑, *CYP1A2↑, *GSTs↑, *NQO1↑, AntiTum↑, AntiCan↑, TumAuto↓, Let-7↑, miR-34a↑, TumCMig↓, Apoptosis↑, MMP↓, mtDam↑, ROS↑, TumCCA↑, other↝, PSA↓, Dose↝, MMP2↓, MMP3↓, MMP9↓, EGFR↓, RAS↓, PI3K↓, Akt↓, mTOR↓, CDK4↓, cycD1/CCND1↓, P21↑, MDM2↓, TumCP↓, NF-kB↓, RANKL↓, PUMA↓, Wnt↓, MTA2↓, EZH2↓, AhR↓, PTEN↑, NOTCH1↓, IRAK1↓, p27/CDKN1B↓, CDKN1C/p57↓, CDC25↓, EGFR↓, Zeb1↓, FOXM1↓, SOX4↓, E-cadherin↑, uPA↓, uPAR↓,
8844- DIM,  I3C,    Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review
- Review, Var, NA - Review, AD, NA - Review, Stroke, NA
*antiOx↑, *Inflam↓, *Apoptosis↓, *Imm↝, *BioAv↝, *Half-Life↝, *PKCδ↓, *TGF-β1↓, *PPARγ↓, *CEBPA↓, *FABP4↓, *AMPKα↑, *MCP1/CCL2↓, *IL6↓, *TNF-α↓, *Akt↑, *Inflam↓, *TMAO↓, *SREBF2⇅, *memfluid↑, *GutMicro↑, *Obesity↓, *hepatoP↑, *neuroP↑, *AntiAg↓, *Stroke↓, *AntiAg↓, *HDAC↑, *IL1β↓, *IL6↓, *iNOS↓, *IL4↑, *IL10↑, *Synergy↑, *compI↑, *ROS↓, *AChE↓, *BChE↓, *MAOA↓, *MAOB↓, *cognitive↑, *Analgesic↑, *Pain↓, *BDNF↑, *TrkB↑, *Akt↑, *antiOx↑, *Apoptosis↓, *cardioP↑, *chemoP↑, *AntiThr↑, *uPA↑, *NRF2↑, *ARE↑, *HO-1↑, *Bacteria↓, *TOP1↓, *AntiFungal↑, *AntiViral↑, *radioP↑, *Synergy↑, *hepatoP↑, *Diar↓, *ChemoSen↑, *Telomerase↓, *BioAv↓,
4989- Dipy,    Dipyridamole
- Review, Nor, NA
*AntiAg↑,
6732- Dipy,    Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway
- in-vivo, Nor, NA
*BloodF↑, *NO↑, *AntiAg↑, *AntiThr↑, *antiOx↑, *angioG↑,
6729- Dipy,    Dipyridamole prevents triple-negative breast-cancer progression
- Trial, BC, MDA-MB-231
TumCG↓, TumMeta↑, β-catenin/ZEB1↓, *AntiAg↑, TumCCA↑, Wnt↓, NF-kB↓,
6730- Dipy,  ASA,    Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner
- vitro+vivo, CRC, NA
*AntiThr↑, Synergy↑, ER Stress↑, UPR↑, *AntiAg↑, *COX1↓, Risk↓, TumCG↓, Apoptosis↑, HMG-CoA↓, *Inflam↓, *antiOx↓,
6731- Dipy,    Dipyridamole, an underestimated vascular protective drug
- Review, Nor, NA
*AntiAg↑,
6735- Dipy,    Dipyridamole Reverses Peripheral Ischemia and Induces Angiogenesis in the Db/Db Diabetic Mouse Hind Limb Model by Decreasing Oxidative Stress
- in-vivo, Nor, NA
*AntiAg↑, *BloodF↑, *NOX↑, *antiOx↑, *NO↑,
6737- Dipy,    Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD)
- Trial, Nor, NA
*AntiAg↑, *Inflam↓, *AntiThr↑, *Dose↝,
6357- DRE,    New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases
- Review, Nor, NA
*cardioP↑, *Ingr↝, *Ingr↝, *toxicity∅, *toxicity↓, *BP↓, *Inflam↓, *Bacteria↓, *Imm↑, *lipid-P↓, *AST↓, *ALAT↓, *AntiAg↑, *ROS↓, *AntiThr↑,
4341- EA,    Novel Bioactivity of Ellagic Acid in Inhibiting Human Platelet Activation
- in-vitro, Nor, NA
*AntiAg↑, *AntiAg↑,
7228- EGb 761,    Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders
- Review, AD, NA
*Dose↝, *PAF↑, *AntiAg↑, *BloodF↑, *Inflam↓, *neuroP↑, *Stroke↓, *Dose↝, *Sepsis↓, *memory↑,
7241- EGb 761,  ASA,    Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial
- Trial, Nor, NA
*Dose↝, *AntiAg∅,
2561- EGCG,  ASA,    Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
- ex-vivo, Nor, NA
AntiAg↑, eff↑, Half-Life↝, other∅,
2562- EGCG,    Green Tea Epigallocatechin 3-Gallate Reduced Platelet Aggregation and Improved Anticoagulant Proteins in Patients with Transfusion-Dependent β-Thalassemia: A Randomized Placebo-Controlled Clinical Trial
- Trial, Nor, NA
*AntiAg↑, *other↝,
2563- EGCG,    Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies
- Review, Stroke, NA
*cardioP↑, *ROS↓, *AntiAg↑, *eff↑, *COX1↓,
2468- EGCG,    Green tea epigallocatechin-3-gallate inhibits platelet signalling pathways triggered by both proteolytic and non-proteolytic agonists
- in-vitro, Nor, NA
*AntiAg↑, *Ca+2↓,
6820- EMD,    The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb—A Summary Update
- Review, Nor, NA - Review, Arthritis, NA - Review, AD, NA
*diuretic↑, *Bacteria↓, *Inflam↓, AntiCan↑, TumCP↓, TumCI↓, angioG↓, *toxicity↓, IFN-γ↑, IL12↑, ROS↑, TNF-α↓, TNF-α↓, TGF-β↓, MAPK↓, PKCδ↓, NF-kB↓, HER2/EBBR2↓, VEGF↓, DNAdam↑, Necroptosis↑, Glycolysis↓, GLUT1↓, PI3K↓, Akt↓, Casp9↑, Casp3↑, BAX↑, Bcl-2↓, Synergy↑, MMP2↓, MMP9↓, Synergy↑, ChemoSen↑, P-gp/ABCB1↓, SREBP2↓, Synergy↑, *other↝, *COX2/PTGS2↓, *Hif1a↓, *HDAC↓, *tau↓, *PKCδ↑, *ROS↓, *Inflam↓, AntiAg?, *antiAll↑,
6381- Eug,    Biological Properties and Prospects for the Application of Eugenol—A Review
- Review, Var, NA
*eff↑, *BioAv↝, *CompStab↝, *BioAv↑, *antiOx↑, *AntiAg↑, *Inflam↓, *AntiBio↑, *MAOA↓, *neuroP↑, *ROS↓, *RNS↓, *Synergy↑, NF-kB↓, PGE2↓, COX2/PTGS2↓, TumCCA↑, Apoptosis↑, TumCMig↓, TumCI↓, tumCV↓, PI3K↓, Akt↓, MMPs↓, ChemoSen↑, ALDH↓, *Pain↓, *VGSC↓, *IL1β↓, *IL6↓, *TNF-α↓, *iNOS↓, *5LO↓, *chemoPv↑, *antiAll↑,
6923- Flav,    Flavonoids: an overview
- Review, Nor, NA
*antiOx↑, AntiCan↑, *cardioP↑, *XO↓, *COX2/PTGS2↓, *5LO↓, *PI3K↓, *AChE↓, *Imm⇅, *BP↓, TumCCA↑, *Aβ↓, *BACE/β-secretase↓, *NF-kB↓, *ROS↓, *neuroP↑, *AntiAg↑, *AntiThr↑,
8589- FS,    Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
- Study, Var, NA
Risk↓, Ingr?, *antiOx?, *Inflam↓, *Estro↓, *Ingr↑, *neuroP↑, *Obesity↓, TumMeta↓, TumCP↓, *AntiAg↑, *AntiDiabetic↑, *ROS↓, *GutMicro↑, FOXM1↓, PCNA↓, Ki-67↓, CDK2↓, Akt↓, PDGF↓, ERK↓, p‑GSK‐3β↓, IGFR↓, p‑MDM2↓, EGFR↓, FASN↓, CYP3A4↓, COX2/PTGS2↓, Cyt‑c↑, cl‑PARP↑, Casp3↑, p‑P53↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, BRCA1↓, BRCA2↓, survivin↓, GADD45A↓, FAK↓, pax↓, Rho↓, Rac1↓, Cdc42↓, MMP2↓, TIMP1↑, TIMP2↑, angioG↓, MMP↓, ChemoSen↑,
824- GAR,    Garcinol A Novel Inhibitor of Platelet Activation and Apoptosis
- in-vitro, Var, NA
AntiAg↓,
7190- GBE,    Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis
- Review, Nor, NA
*AntiAg∅, *other∅,
3722- GBE,    Alzheimer's disease: Research summaries – Do Ginkgo products help?
- Review, AD, NA
*memory↑, *AntiAg↑,
7217- GGB,    Role of Ginkgolides in the Inflammatory Immune Response of Neurological Diseases: A Review of Current Literatures
- Review, AD, NA
*eff↑, *AntiAg↑, *Apoptosis↓, *antiOx↑, *Inflam↓, *MAPK↓, *NF-kB↓, *PAF↓, *TLR1↓, *MyD88↓, *BDNF↑, *ROS↓, *PARP↓, *Cyt‑c↓,
2464- GI,    The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review
- Review, Nor, NA
*Inflam↓, *antiOx↑, *LDL↓, *AntiAg↑, *AntiAg∅,
2465- GI,    Effect of daily ginger consumption on platelet aggregation
- Trial, Nor, NA
AntiAg↝, Dose∅,
4347- H2,    Hydrogen may inhibit collagen-induced platelet aggregation: an ex vivo and in vivo study
- ex-vivo, Nor, NA
*AntiAg↑,
4346- H2,    Medical Application of Hydrogen in Hematological Diseases
- Review, Var, NA
*AntiAg↑, *TNF-α↓, *IL6↓, *IFN-γ↓, *NF-kB↓,
4345- H2,    The Benefit of Hydrogen Gas as an Adjunctive Therapy for Chronic Obstructive Pulmonary Disease
- Human, Var, NA
*Inflam↓, *antiOx↑, *ROS↓, *NLRP3↑, *NF-kB↓, *SOD↑, *Catalase↑, *AntiAg↑,
4344- H2,    Hydrogen May Inhibit Collagen-Induced Platelet Aggregation: An ex vivo and in vivo Study
- in-vivo, Nor, NA - ex-vivo, Nor, NA
*AntiAg↑,
4343- H2,    Inhibitory effects of hydrogen on in vitro platelet activation and in vivo prevention of thrombosis formation
- vitro+vivo, Nor, NA
*antiOx↑, *AntiAg↑, *NO↑, *ERK↑,
3770- H2,    Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases
- Review, AD, NA - Review, Park, NA
*antiOx↑, *NRF2↑, *HO-1↑, *Inflam↓, *neuroP↑, *cardioP↑, *other↓, *ROS↓, *NADPH↓, *Catalase↑, *GPx1↑, *NO↓, *mt-ROS↓, *SIRT3↑, *SIRT1↑, *TLR4↓, *mTOR↓, *cognitive↑, *Sepsis↓, *PTEN↓, *Akt↓, *NLRP3↓, *AntiAg↑, *IL6↓, *TNF-α↓, *IL1β↓, *MDA↓, *memory↑, *FOXO3↑, TumCG↓, *LDL↓,
2894- HNK,    Pharmacological features, health benefits and clinical implications of honokiol
- Review, Var, NA - Review, AD, NA
*BioAv↓, *neuroP↑, *BBB↑, *ROS↓, *Keap1↑, *NRF2↑, *Casp3↓, *SIRT3↑, *Rho↓, *ERK↓, *NF-kB↓, angioG↓, RAS↓, PI3K↓, Akt↓, mTOR↓, *memory↑, *Aβ↓, *PPARγ↑, *PGC-1α↑, NF-kB↓, Hif1a↓, VEGF↓, HO-1↓, FOXM1↓, p27/CDKN1B↑, P21↑, CDK2↓, CDK4↓, CDK6↓, cycD1/CCND1↓, Twist↓, MMP2↓, Rho↑, ROCK1↑, TumCMig↓, cFLIP↓, BMPs↑, OCR↑, ECAR↓, *AntiAg↑, *cardioP↑, *antiOx↑, *ROS↓, P-gp/ABCB1↓,
7769- IBC,    Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters
- in-vivo, Var, NA
*AntiCan↑, *AntiAg↑, *AntiFungal↑, CYP2C9↓, UGT1A↓, CYP2D6↓, CYP2E1↓,
9254- ISO, IH,    Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
- Review, Var, NA
MMP2↓, MMP9↓, MAPK↓, STAT3↓, Akt↓, mTOR↓, MEK↓, ERK↓, TumCP↓, TumCM/A↓, LDH↓, EMT↓, Casp3↑, Cyt‑c↑, BAX↑, cl‑Casp3↑, cl‑PARP↑, TumCCA?, AMPK↑, ROS↑, COX2/PTGS2↓, *cardioP↑, *hepatoP↑, *neuroP↑, *RenoP↑, *AntiViral↑, *antiCG↑, *AntiAg↑, *AntiThr↑,
7737- isoFl,    An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health
- Review, Nor, NA
*cardioP↑, Risk↓, *BMD↑, *eff↑, *antiOx↑, *lipid-P↓, *LDL↓, AntiThr↑, AntiAg↑, PSA↓, TumCCA↑, cognitive↑, memory↑,
7917- IVT,    A review on the pharmacological effects of vitexin and isovitexin
- Review, Nor, NA - Review, AD, NA
*antiOx↑, *AntiCan↑, *Inflam↓, *neuroP↑, *AChE↓, *BChE↓, *BACE/β-secretase↓, *Stroke↓, *AntiAg↓, *AntiDiabetic↑, *AGEs↓, *IL1β↓, *IL6↓, *IL8↓, *TNF-α↓, *Obesity↓, *BioAv↝, *BioAv↓,
7897- IVT,  VT,    Vitexin and isovitexin delayed ageing and enhanced stress-resistance through the activation of the SKN-1/Nrf2 signaling pathway
- in-vitro, Nor, NA
*antiOx↑, *ROS↓, *OS↑, *NRF2↑, *AntiAg↑,
4010- K+,    Potassium-sparing diuretics might reduce risk of Alzheimer's disease
- Review, AD, NA
*Risk↓, *ROS↓, *Inflam↓, *AntiAg↑,
8278- LE,    Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology
- Review, Var, NA
*Ingr↝, *AntiCan↑, *AntiDiabetic↑, *AntiBio↑, *Inflam↓, *antiAll↑, *hepatoP↑, *cough?, *SoreThr?, *toxicity↝, *cardioP↑, *BioAv↝, *PGE2↓, *COX2/PTGS2↓, *AntiAg↑, *ROS↓, *NLRP3↓, *NF-kB↓, *AP-1↓, TumCCA↑, Apoptosis↑, TumMeta↑, *Dose↝, *Dose↝, Ingr↝, TumAuto↑, LC3II↑, PI3K↓, Akt↓, mTOR↓, *cognitive↑, *BloodF↑, ChemoSen↑, ROS↓, *chemoP↑, ROS↑, tumCV↓, MMP↓, *AntiBio↑, *toxicity↝,
8396- LT,  Myr,  KAE,  QC,  Api  Antiplatelet Effects of Flavonoid Aglycones Are Mediated by Activation of Cyclic Nucleotide-Dependent Protein Kinases
- in-vivo, Nor, NA
*other↝, *AntiAg↑, *ROS↓,
4338- LT,    Luteolin: a natural product with multiple mechanisms for atherosclerosis
- Review, Var, NA
*Inflam↓, *ROS↓, *PDGF↓, *lipid-P↓, *AMPK↑, *SIRT1↑, *AntiAg↑,
4339- LT,    Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis
- in-vivo, Nor, NA
*AntiAg↑, *ROS↓,
3261- Lyco,    Lycopene and Vascular Health
- Review, Stroke, NA
*Inflam↓, *antiOx↑, *AntiAg↑, *cardioP↑, *SOD↑, *Catalase↑, *ROS↓, *mtDam↓, *cardioP↑, *NF-kB↓, *NO↓, *COX2/PTGS2↓, *LDL↓, *Synergy↑, *ER Stress↓, *BioAv↑, *Synergy↑, *MMPs↓, *COX2/PTGS2↓, *RAGE↓,

Showing Research Papers: 51 to 100 of 128
Prev Page 2 of 3 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 128

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

GPx↑, 1,   GSH↓, 1,   H2O2↑, 1,   HO-1↓, 1,   HO-1↑, 1,   lipid-P↓, 1,   lipid-P↑, 1,   NRF2↑, 1,   RNS↑, 1,   ROS↓, 2,   ROS↑, 18,   ROS↝, 1,   i-ROS↑, 1,   mt-ROS↑, 1,   SOD2↓, 1,   Trx↓, 1,   TrxR1↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC25↓, 2,   compIV↓, 1,   mtDam↑, 2,   OCR↑, 1,   SDH↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ALAT↓, 1,   AMPK↑, 3,   ECAR↓, 1,   FASN↓, 2,   GLO-I↓, 1,   GlucoseCon↓, 1,   Glycolysis↓, 2,   p‑GSK‐3β↓, 2,   HK2↓, 1,   HMG-CoA↓, 2,   lactateProd↓, 3,   SREBP2↓, 2,   SREBP2↑, 1,   TumCM/A↓, 1,   Warburg↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 2,   APAF1↑, 2,   Apoptosis↓, 2,   Apoptosis↑, 10,   BAD↑, 1,   Bak↑, 1,   BAX↑, 7,   Bax:Bcl2↑, 2,   Bcl-2↓, 10,   Bcl-xL↓, 1,   Casp↑, 4,   Casp3↓, 2,   Casp3↑, 11,   cl‑Casp3↑, 2,   Casp6↑, 1,   cl‑Casp7↑, 1,   Casp8↑, 2,   cl‑Casp8↑, 1,   Casp9↑, 6,   cl‑Casp9↑, 1,   cFLIP↓, 3,   Cyt‑c↑, 9,   Diablo↑, 1,   DR5↓, 1,   cl‑IAP2/BIRC3↑, 1,   iNOS↓, 2,   Mcl-1↓, 3,   MDM2↓, 1,   p‑MDM2↓, 1,   Necroptosis↑, 1,   p38↓, 1,   p38↑, 3,   p‑p38↑, 1,   PUMA↓, 1,   survivin↓, 4,   XIAP↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 17,   p‑Akt↓, 4,   CK2↓, 2,   EGFR↓, 6,   ERK↓, 7,   p‑ERK↓, 2,   HER2/EBBR2↓, 2,   IGFR↓, 1,   JAK↓, 1,   JNK↓, 1,   JNK↑, 2,   p‑JNK↓, 1,   MAPK↓, 4,   MAPK↑, 3,   MEK↓, 1,   mTOR↓, 8,   p‑mTOR↓, 2,   PI3K↓, 14,   PKCδ↓, 3,   PTEN↓, 1,   PTEN↑, 5,   e-Raf↓, 1,   RAS↓, 3,   STAT↓, 1,   STAT3↓, 7,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,   cMyc↓, 5,   DNMTs↓, 1,   EZH2↓, 1,   FOXM1↓, 4,   FOXO3↓, 1,   ac‑H3↑, 1,   ac‑H4↑, 1,   HDAC↓, 1,   miR-34a↑, 1,   MTA2↓, 1,   Myc↓, 1,   other?, 4,   other↑, 3,   other↝, 2,   other∅, 1,   SOX4↓, 1,   tumCV↓, 4,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↑, 4,   HSPs↓, 1,   UPR↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3II↑, 1,   TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

BRCA1↓, 1,   BRCA2↓, 1,   DNAdam↑, 5,   P53↓, 1,   P53↑, 6,   p‑P53↑, 1,   p73↑, 1,   cl‑PARP↑, 6,   PARP1↑, 1,   PCNA↓, 3,   Telomerase↓, 3,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 2,   CDK2↓, 5,   CDK4↓, 6,   CDK6↓, 3,   CDKN1C/p57↓, 1,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 2,   cycD1/CCND1↓, 7,   cycE/CCNE↓, 2,   GADD45A↓, 1,   Ki-67↓, 2,   P21↑, 6,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 3,   p‑pRB↓, 1,   TumCCA?, 1,   TumCCA↑, 17,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   BMPs↑, 1,   HMGCR↓, 1,   IGF-1↓, 1,   IGFBP3↑, 1,   Ki-67↓, 2,   Let-7↑, 1,   NOTCH↓, 1,   NOTCH1↓, 1,   STAT1↓, 1,   TumCG↓, 6,   TumCP↓, 9,   TumCP↑, 1,   Wnt↓, 4,  

Migration(tgid=13) ⓘ

AntiAg?, 1,   AntiAg↓, 2,   AntiAg↑, 12,   AntiAg↝, 1,   AntiAg∅, 1,   AP-1↓, 1,   Ca+2↓, 1,   Ca+2↑, 5,   cal2↑, 1,   Cdc42↓, 1,   E-cadherin↑, 5,   EMT↓, 5,   FAK↓, 2,   ITGB4↓, 1,   MMP13↓, 1,   MMP2↓, 13,   MMP3↓, 2,   MMP7↓, 2,   MMP9↓, 14,   MMP9↑, 1,   MMPs↓, 4,   N-cadherin↓, 1,   pax↓, 1,   PDGF↓, 1,   Rac1↓, 1,   Rho↓, 1,   Rho↑, 1,   ROCK1↑, 1,   Slug↓, 1,   Snail↓, 1,   TGF-β↓, 2,   TIMP1↑, 3,   TIMP2↑, 2,   TSP-1↑, 1,   TumCI↓, 6,   TumCMig↓, 7,   TumMeta↓, 8,   TumMeta↑, 2,   Twist↓, 2,   uPA↓, 3,   uPAR↓, 1,   Vim↓, 2,   Zeb1↓, 1,   β-catenin/ZEB1↓, 4,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 7,   HIF-1↑, 1,   Hif1a↓, 5,   NO↓, 2,   TXA2↓, 2,   VCAM-1↓, 1,   VEGF↓, 7,   VEGFR2/KDR/Flk1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

CLDN2↓, 1,   GLUT1↓, 2,   MMP↓, 8,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX1↓, 4,   COX2/PTGS2↓, 12,   CXCL12↓, 1,   CXCR4↓, 2,   IFN-γ↑, 1,   IL10↓, 1,   IL10↑, 1,   IL12↑, 1,   IL6↓, 3,   Imm↑, 1,   Inflam↓, 3,   IRAK1↓, 1,   NF-kB↓, 12,   NF-kB↑, 1,   PD-L1↓, 1,   PGE2↓, 6,   PSA↓, 5,   TNF-α↓, 3,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 1,   AR↓, 2,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 3,   BioAv↝, 4,   BioEnh?, 1,   ChemoSen↑, 13,   CompStab↓, 1,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP2C9↓, 1,   CYP2D6↓, 1,   CYP2E1↓, 1,   CYP3A4↓, 1,   Dose↑, 1,   Dose↝, 3,   Dose∅, 1,   eff↑, 6,   Half-Life↓, 1,   Half-Life↝, 4,   P-gp/ABCB1↓, 3,   RadioS↑, 2,   selectivity↑, 3,   Synergy↑, 14,   UGT1A↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   AR↓, 2,   BRCA1↓, 1,   EGFR↓, 6,   EZH2↓, 1,   FOXM1↓, 4,   HER2/EBBR2↓, 2,   IL6↓, 3,   LDH↓, 1,   Myc↓, 1,   PD-L1↓, 1,   PSA↓, 5,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 6,   AntiTum↑, 6,   cardioP↑, 1,   chemoP↑, 5,   chemoPv↑, 3,   cognitive↑, 2,   hepatoP↑, 2,   memory↑, 1,   neuroP↑, 1,   PDE4↓, 1,   radioP↑, 1,   RenoP↑, 1,   Risk↓, 9,   Risk↑, 1,   toxicity↝, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 1,  
Total Targets: 297

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 2,   antiOx↑, 42,   ARE↑, 1,   Catalase↑, 9,   Fenton↓, 1,   GPx↑, 5,   GPx1↑, 1,   GSH↑, 5,   GSR↑, 1,   GSTs↑, 4,   H2O2↓, 2,   HDL↑, 3,   HO-1↑, 6,   Keap1↑, 1,   lipid-P↓, 10,   mt-lipid-P↓, 1,   MDA↓, 7,   MPO↓, 2,   NADH↓, 1,   NOX↓, 1,   NOX↑, 1,   NQO1↑, 3,   NRF2↑, 11,   RNS↓, 2,   ROS↓, 37,   ROS↑, 3,   ROS⇅, 1,   mt-ROS↓, 1,   selenoP↑, 1,   SOD↑, 9,   TBARS↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↓, 1,   IronCh↑, 1,   Mets↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   Insulin↑, 2,   mtDam↓, 1,   PGC-1α↑, 2,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↑, 1,   5LO↓, 4,   Acetyl-CoA↓, 1,   ALAT↓, 2,   AMPK↑, 3,   ATP↑, 2,   FABP4↓, 1,   FAO↑, 1,   FASN↓, 1,   glucose↓, 1,   GSK‐3β↓, 1,   H2S↑, 1,   LDL↓, 8,   NADH:NAD↑, 1,   NADPH↓, 2,   NADPH↑, 1,   SIRT1↑, 4,   SREBF2⇅, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   Casp3↓, 1,   Cyt‑c↓, 1,   Cyt‑c∅, 1,   Ferroptosis↓, 1,   iNOS↓, 4,   necrosis↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 3,   AMPKα↑, 1,   ERK↓, 1,   ERK↑, 1,   JNK↓, 2,   MAPK↓, 2,   mTOR↓, 1,   PI3K↓, 2,   PI3K↑, 1,   PKCδ↓, 2,   PKCδ↑, 2,   PP2A↑, 1,   PTEN↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 13,   FOXO↑, 1,   FOXO3↑, 1,   HDAC↓, 1,   HDAC↑, 1,   other?, 3,   other↓, 3,   other↑, 9,   other↝, 9,   other∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↓, 2,   ER Stress↑, 1,   HSP70/HSPA5↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

PARP↓, 1,   Telomerase↓, 1,   TOP1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

CEBPA↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↓, 5,   AntiAg↑, 109,   AntiAg∅, 3,   AP-1↓, 1,   Ca+2↓, 1,   Ca+2↑, 2,   Cartilage↑, 1,   MMP9↓, 1,   MMPs↓, 1,   PDGF↓, 1,   Rho↓, 1,   TGF-β1↓, 1,   TumMeta↓, 1,   uPA↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 2,   Hif1a↓, 1,   NO↓, 4,   NO↑, 3,   P-sel↓, 1,   TXA2↓, 6,   TXA2↑, 1,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 2,   CLDN1↓, 1,   GastroP↑, 3,   memfluid↑, 1,   MMP↑, 1,   OCLN↓, 1,   TJ↓, 1,   TRPM7↓, 1,   TRPV1↑, 2,   TRPV3↑, 1,   VGSC↓, 1,   ZO-1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD40↓, 1,   COX1↓, 10,   COX2/PTGS2↓, 15,   IFN-γ↓, 1,   IL10↓, 1,   IL10↑, 1,   IL1β↓, 7,   IL4↑, 1,   IL6↓, 7,   IL8↓, 3,   Imm↑, 6,   Imm⇅, 1,   Imm↝, 1,   Inflam↓, 50,   Inflam↑, 1,   IP-10/CXCL-10↓, 1,   MCP1/CCL2↓, 1,   MyD88↓, 1,   NF-kB↓, 16,   NLRP3↓, 3,   NLRP3↑, 2,   p65↓, 1,   PAF↓, 1,   PAF↑, 1,   PGE2↓, 2,   RAGE↓, 1,   TLR1↓, 1,   TLR4↓, 3,   TNF-α↓, 9,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 7,   ADAM10↑, 1,   BChE↓, 4,   BDNF↑, 2,   MAOA↓, 2,   MAOB↓, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 4,   BACE/β-secretase↓, 3,   tau↓, 1,   p‑tau↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Estro↓, 1,   PPARγ↓, 1,   PPARγ↑, 2,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 10,   BioAv↑, 13,   BioAv⇅, 1,   BioAv↝, 12,   ChemoSen↑, 1,   CompStab↝, 1,   CYP1A1↑, 1,   CYP1A2↑, 1,   Dose↝, 19,   eff↓, 1,   eff↑, 15,   Half-Life↓, 2,   Half-Life↝, 3,   Synergy↑, 9,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AST↓, 3,   BloodF↑, 4,   BMD↑, 1,   BP↓, 12,   CRP↓, 1,   IL6↓, 7,   LDH↓, 1,   NOS2↓, 1,   RAGE↓, 1,   TMAO↓, 1,   TMAO↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   antiAll↑, 6,   AntiCan↑, 7,   antiCG↑, 1,   AntiDiabetic↓, 1,   AntiDiabetic↑, 9,   AntiTum↑, 1,   cardioP↑, 30,   chemoP↑, 2,   chemoPv↑, 4,   cognitive↓, 2,   cognitive↑, 10,   cough?, 1,   diuretic↑, 1,   hepatoP↑, 14,   memory↑, 6,   motorD↑, 2,   neuroP↑, 23,   Obesity↓, 8,   OS↑, 2,   Pain↓, 8,   radioP↑, 2,   RenoP↑, 4,   Risk↓, 3,   SoreThr?, 1,   Stroke↓, 4,   toxicity↓, 10,   toxicity↝, 7,   toxicity∅, 1,   Weight↓, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiFungal↑, 5,   AntiViral↑, 2,   Bacteria↓, 15,   Diar↓, 2,   GutMicro↑, 6,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 4,  
Total Targets: 242

Scientific Paper Hit Count for: AntiAg, Antiplatelet aggregation
11 Allicin (mainly Garlic)
11 Aspirin
9 Dipyridamole
9 Resveratrol
8 Silver-NanoParticles
6 Hydrogen Gas
5 EGCG (Epigallocatechin Gallate)
4 Ginger/6-Shogaol/Gingerol
4 Lycopene
4 Carvacrol
4 Chocolate
4 Quercetin
3 Capsaicin
3 Luteolin
2 Eugenol
2 Vitamin E
2 Apigenin (mainly Parsley)
2 Atorvastatin
2 Chlorogenic acid
2 Curcumin
2 Diclofenac
2 Diindolylmethane
2 Indole-3-carbinol
2 Ginkgo biloba-EGb 761
2 Ginkgo biloba
2 Isovitexin
2 Magnolol
2 Piperlongumine
2 Rutin
1 1,8-Cineole
1 Ajoene (compound of Garlic)
1 Selenium
1 Ginseng
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 DTS(dibenzyl trisulphide) from Anamu
1 Anethole/trans-Anethole
1 Aloe anthraquinones
1 Berberine
1 Benzyl isothiocyanate
1 Phenethyl isothiocyanate
1 Allyl isothiocyanate
1 Caffeic acid
1 Choline
1 Cinnamon
1 Dandelion Root
1 Ellagic acid
1 Emodin
1 flavonoids
1 Flaxseed/Linseed
1 Garcinol
1 Ginkgolide B
1 Honokiol
1 Isobavachalcone
1 Isorhamnetin
1 isoflavones
1 Vitexin
1 Potassium
1 Licorice
1 Myricetin
1 Kaempferol
1 Mangiferin
1 Naringin
1 Oleocanthal
1 Marjoram (Origanum majorana)
1 Phenolic Acids
1 Hydroxycinnamic-acid
1 Phycocyanin
1 Genistein (soy isoflavone)
1 Echistatin
1 Fisetin
1 Selenium NanoParticles
1 Thymol-Thymus vulgaris
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:10  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page